BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Chen XY, Wang C, Huang YZ, Zhang LL. Nonalcoholic fatty liver disease shows significant sex dimorphism. World J Clin Cases 2022; 10(5): 1457-1472 [PMID: 35211584 DOI: 10.12998/wjcc.v10.i5.1457]
URL: https://www.wjgnet.com/1007-9327/full/v10/i5/1457.htm
Number Citing Articles
1
Chong Hu, Ziqi Yu, Changli Wei, Guotai Sheng, Jianyong Chen, Yang Zou. Evaluating the relative importance of different blood pressure indices in screening for NAFLD: a survey report based on a health examination populationFrontiers in Cardiovascular Medicine 2024; 11 doi: 10.3389/fcvm.2024.1338156
2
Seong-Uk Baek, Jin-Ha Yoon. High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic DysfunctionBiomolecules 2024; 14(11): 1468 doi: 10.3390/biom14111468
3
Ravi Sonkar, Hong Ma, David J Waxman. Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progressionToxicological Sciences 2024; 200(2): 324 doi: 10.1093/toxsci/kfae057
4
Siti Aishah Sulaiman, Vicneswarry Dorairaj, Muhammad Nafiz Haidi Adrus. Genetic Polymorphisms and Diversity in Nonalcoholic Fatty Liver Disease (NAFLD): A Mini ReviewBiomedicines 2022; 11(1): 106 doi: 10.3390/biomedicines11010106
5
Xiulu Guan, Shiyuan Shen, Jinxia Liu, Hongru Song, Jinhua Chang, Xiaoxia Mao, Jingyu Song, Lin Zhang, Cuizhe Liu. Protective effects of baicalin magnesium on non-alcoholic steatohepatitis rats are based on inhibiting NLRP3/Caspase-1/IL-1β signaling pathwayBMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-03903-2
6
Tengrui Cao, Chao Tong, Qiang Li, Yumei Han, Aheyeerke Halengbieke, Xuetong Ni, Bo Gao, Deqiang Zheng, Xinghua Yang. Association of sex-specific body mass index and waist circumference trajectories with non-alcoholic fatty liver disease incidence based on growth mixture modelingNutrition, Metabolism and Cardiovascular Diseases 2024; 34(5): 1245 doi: 10.1016/j.numecd.2024.01.001
7
Andrea G. Izquierdo, Marcos C. Carreira, Gemma Rodriguez-Carnero, Raquel Perez-Lois, Luisa M. Seoane, Felipe F. Casanueva, Ana B. Crujeiras. Gender Dimorphism in Hepatic Carcinogenesis-Related Gene Expression Associated with Obesity as a Low-Grade Chronic Inflammatory DiseaseInternational Journal of Molecular Sciences 2022; 23(23): 15002 doi: 10.3390/ijms232315002
8
María Fernanda Castillo, Daniela Salgado-Canales, Marco Arrese, Francisco Barrera, Dimitri P Mikhailidis. Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic ReviewCurrent Vascular Pharmacology 2024; 22(3): 187 doi: 10.2174/0115701611285401240110074530
9
Tomoki Sempokuya, Josh Warner, Muaataz Azawi, Akane Nogimura, Linda L Wong. Current status of disparity in liver diseaseWorld Journal of Hepatology 2022; 14(11): 1940-1952 doi: 10.4254/wjh.v14.i11.1940
10
Lucia De la Cruz-Color, Jose Alfredo Dominguez-Rosales, Montserrat Maldonado-González, Bertha Ruíz-Madrigal, Martha P. Sánchez Muñoz, Vianney Alejandrina Zaragoza-Guerra, Victor H. Espinoza-Padilla, Elizabeth del C. Ruelas-Cinco, Sandra M. Ramírez-Meza, José R. Torres Baranda, María del R. González-Gutiérrez, Zamira Helena Hernandez Nazara. Evidence That Peripheral Leptin Resistance in Omental Adipose Tissue and Liver Correlates with MASLD in HumansInternational Journal of Molecular Sciences 2024; 25(12): 6420 doi: 10.3390/ijms25126420
11
Anna Marsal-Beltran, Adrià Rodríguez-Castellano, Brenno Astiarraga, Enrique Calvo, Patricia Rada, Ana Madeira, M-Mar Rodríguez-Peña, Gemma Llauradó, Catalina Núñez-Roa, Beatriz Gómez-Santos, Elsa Maymó-Masip, Ramon Bosch, María Dolores Frutos, José María Moreno-Navarrete, Bruno Ramos-Molina, Patricia Aspichueta, Jorge Joven, José-Manuel Fernández-Real, Juan Carlos Quer, Ángela M. Valverde, Albert Pardo, Joan Vendrell, Victòria Ceperuelo-Mallafré, Sonia Fernández-Veledo. Protective effects of the succinate/SUCNR1 axis on damaged hepatocytes in NAFLDMetabolism 2023; 145: 155630 doi: 10.1016/j.metabol.2023.155630
12
Mohamad Jamalinia, Amedeo Lonardo, Ralf Weiskirchen. Sex and Gender Differences in Liver Fibrosis: Pathomechanisms and Clinical OutcomesFibrosis 2024; 2(1): 10006 doi: 10.70322/fibrosis.2024.10006
13
Kasimu Ghandi Ibrahim, Eliton Chivandi, Kennedy Honey Erlwanger, Richard Leslie Brooksbank. Neonatal administration of fenofibrate had no developmental programming effect on the lipid profile and relative leucocyte telomere lengths of adolescent rats fed a high-fructose diet postnatallyCanadian Journal of Physiology and Pharmacology 2023; 101(11): 565 doi: 10.1139/cjpp-2022-0528
14
Yan Gong, Juan Kang, Xinyan Wang, Yansong Zheng, Ying Sui, Wenping Lu. Increased detection rates of advanced colorectal adenoma in women with metabolic dysfunction-associated fatty liver diseaseHeliyon 2023; 9(11): e22391 doi: 10.1016/j.heliyon.2023.e22391